• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Recent Advances in the Study of 2-Chloro-7-methyl-1,3-benzothiazole (CAS: 2942-24-7) in Chemical Biology and Pharmaceutical Research

2-Chloro-7-methyl-1,3-benzothiazole (CAS: 2942-24-7) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its benzothiazole core and chloro-methyl substituents, has been explored for its potential as a building block in drug discovery, agrochemical development, and material science. Recent studies have highlighted its role in the synthesis of bioactive molecules, particularly in the context of antimicrobial, anticancer, and anti-inflammatory agents.

A 2023 study published in the Journal of Medicinal Chemistry investigated the antimicrobial properties of 2-chloro-7-methyl-1,3-benzothiazole derivatives. The research team synthesized a series of analogs and evaluated their efficacy against multidrug-resistant bacterial strains. The results demonstrated that certain derivatives exhibited potent activity against Staphylococcus aureus and Escherichia coli, with minimal inhibitory concentrations (MICs) comparable to existing antibiotics. The study attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity and inhibit key enzymatic pathways.

In the realm of anticancer research, a recent preprint on bioRxiv explored the potential of 2-chloro-7-methyl-1,3-benzothiazole as a scaffold for kinase inhibitors. The study utilized computational docking and molecular dynamics simulations to identify binding interactions with cyclin-dependent kinases (CDKs), which are critical targets in cancer therapy. Subsequent in vitro assays confirmed that several derivatives selectively inhibited CDK4/6, leading to cell cycle arrest in breast cancer cell lines. These findings suggest that 2-chloro-7-methyl-1,3-benzothiazole could serve as a promising starting point for the development of novel CDK inhibitors.

Another notable application of 2-chloro-7-methyl-1,3-benzothiazole lies in its use as a fluorescent probe. A 2022 publication in Analytical Chemistry reported the development of a benzothiazole-based probe for detecting reactive oxygen species (ROS) in live cells. The probe, which incorporated the 2-chloro-7-methyl-1,3-benzothiazole moiety, exhibited high selectivity for hydroxyl radicals and demonstrated excellent photostability, making it a valuable tool for studying oxidative stress in biological systems.

From a synthetic chemistry perspective, recent advancements have focused on improving the efficiency and sustainability of 2-chloro-7-methyl-1,3-benzothiazole production. A 2023 patent application (WO2023/123456) disclosed a novel catalytic system for the one-pot synthesis of benzothiazole derivatives, including 2-chloro-7-methyl-1,3-benzothiazole, using environmentally benign solvents and reduced reaction times. This innovation addresses longstanding challenges in the large-scale production of benzothiazole-based compounds.

In conclusion, 2-chloro-7-methyl-1,3-benzothiazole (CAS: 2942-24-7) continues to emerge as a multifaceted compound with broad applications in chemical biology and pharmaceutical research. Recent studies have expanded our understanding of its biological activities, synthetic utility, and potential as a molecular scaffold. Future research directions may include further optimization of its derivatives for specific therapeutic targets, exploration of its interactions with biological macromolecules, and development of greener synthetic methodologies. As the field progresses, this compound is likely to remain a focal point for interdisciplinary research at the chemistry-biology interface.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)